Post

South Korea and Australia on the rise as clinical research hubs

Dr. Yooni Kim, the vice president of clinical services at Novotech, says Australia and South Korea are emerging as bubbling …

Anti-obesity drugs will be 2024’s defining trend

Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development, …

Siegfried to boost drug substances offering with new acquisition

Switzerland-based Siegfried has announced the signing of binding agreements with Curia Global to acquire an early-phase contract development and manufacturing …

Cyrus Biotechnology to spin out Levitate Bio for biopharma AI

Software-enabled biotechnology company Cyrus Biotechnology has announced the spin-out of Levitate Bio to enhance biopharma AI offerings. The new entity will …

Syntis Bio launches oral therapies for metabolic diseases

Clinical-stage biopharmaceutical company Syntis Bio has announced the launch of developments for oral therapies targeting a range of metabolic diseases, …